These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 38712353)
21. Six- and twelve-month documented removal rates among women electing postpartum inpatient compared to delayed or interval contraceptive implant insertions after Medicaid payment reform. Crockett AH; Pickell LB; Heberlein EC; Billings DL; Mills B Contraception; 2017 Jan; 95(1):71-76. PubMed ID: 27400823 [TBL] [Abstract][Full Text] [Related]
22. Early removal of etonogestrel subcutaneous contraceptive implant at a community health centre in Pretoria. Moeti DMP; Govender I; Bongongo T S Afr Fam Pract (2004); 2022 Jul; 64(1):e1-e6. PubMed ID: 35924618 [TBL] [Abstract][Full Text] [Related]
23. Real world data on Nexplanon® procedure-related events: final results from the Nexplanon Observational Risk Assessment study (NORA). Reed S; Do Minh T; Lange JA; Koro C; Fox M; Heinemann K Contraception; 2019 Jul; 100(1):31-36. PubMed ID: 30980829 [TBL] [Abstract][Full Text] [Related]
24. Safety and efficacy of Implanon, a single-rod implantable contraceptive containing etonogestrel. Funk S; Miller MM; Mishell DR; Archer DF; Poindexter A; Schmidt J; Zampaglione E; Contraception; 2005 May; 71(5):319-26. PubMed ID: 15854630 [TBL] [Abstract][Full Text] [Related]
25. Twelve-month discontinuation of etonogestrel implant in an outpatient pediatric setting. Berlan E; Mizraji K; Bonny AE Contraception; 2016 Jul; 94(1):81-6. PubMed ID: 26948183 [TBL] [Abstract][Full Text] [Related]
26. Subdermal Contraceptive Implant Insertion Trends and Retention in Adolescents. Tyson N; Lopez M; Merchant M; Postlethwaite D J Pediatr Adolesc Gynecol; 2021 Jun; 34(3):348-354. PubMed ID: 33388444 [TBL] [Abstract][Full Text] [Related]
28. A 12-month multicenter, randomized study comparing the levonorgestrel intrauterine system with the etonogestrel subdermal implant. Apter D; Briggs P; Tuppurainen M; Grunert J; Lukkari-Lax E; Rybowski S; Gemzell-Danielsson K Fertil Steril; 2016 Jul; 106(1):151-157.e5. PubMed ID: 27016644 [TBL] [Abstract][Full Text] [Related]
29. Bleeding profile in users of an etonogestrel sub-dermal implant: effects of anthropometric variables. An observational uncontrolled preliminary study in Italian population. Di Carlo C; Guida M; De Rosa N; Sansone A; Gargano V; Cagnacci A; Nappi C Gynecol Endocrinol; 2015 Jun; 31(6):491-4. PubMed ID: 26213863 [TBL] [Abstract][Full Text] [Related]
30. [Safety profile of etonogestrel contraceptive implant (Nexplanon Simon C; Agier MS; Béné J; Muller C; Vrignaud L; Marret H; Jonville-Bera AP J Gynecol Obstet Biol Reprod (Paris); 2016 Nov; 45(9):1074-1082. PubMed ID: 27125380 [TBL] [Abstract][Full Text] [Related]
31. Management of etonogestrel subdermal implant-related bleeding. Casey PM; Long ME; Drozdowicz LB; Marnach ML; Weaver AL J Reprod Med; 2014; 59(5-6):306-12. PubMed ID: 24937974 [TBL] [Abstract][Full Text] [Related]
33. Relationship between etonogestrel level and BMI in women using the contraceptive implant for more than 1 year. Morrell KM; Cremers S; Westhoff CL; Davis AR Contraception; 2016 Mar; 93(3):263-5. PubMed ID: 26577754 [TBL] [Abstract][Full Text] [Related]
34. Temporal Trends in the Uptake and Continuation of the Etonogestrel Implant in a Large Private Practice Setting. Howard DL; Ford A; Ceballos S; Volker KW J Womens Health (Larchmt); 2018 Feb; 27(2):191-195. PubMed ID: 28976797 [TBL] [Abstract][Full Text] [Related]
35. Can a 3 months treatment with oral Desogestrel prior to insertion of the etonogestrel-releasing contraceptive implant improve continuation rate at 1 year? A randomized trial. Lombardi Fäh V; Catarino R; Castillo S; Badda M; Gezer-Dickschat S; Thieringer F; Tschudin S; Viviano M; Yaron M BMC Res Notes; 2023 Mar; 16(1):35. PubMed ID: 36915205 [TBL] [Abstract][Full Text] [Related]
36. Amenorrhea in adolescents using the etonogestrel contraceptive implant. Tsevat D; Mercier R; Bernheimer C; Lin S; Schwartz B Contraception; 2024 May; 133():110413. PubMed ID: 38401772 [TBL] [Abstract][Full Text] [Related]
37. Effectiveness and continuation rates of the etonogestrel-subdermal contraceptive implant versus short-acting contraceptive methods offered at no cost in Campinas, Brazil. Laporte M; Marcelino AC; da Cunha Pereira P; Espejo-Arce X; Juliato CT; Bahamondes L Int J Gynaecol Obstet; 2024 Jul; 166(1):305-311. PubMed ID: 38328989 [TBL] [Abstract][Full Text] [Related]
38. Association of body mass index with removal of etonogestrel subdermal implant. Casey PM; Long ME; Marnach ML; Fleming-Harvey J; Drozdowicz LB; Weaver AL Contraception; 2013 Mar; 87(3):370-4. PubMed ID: 22959901 [TBL] [Abstract][Full Text] [Related]
39. Pilot study of a novel, alternative subdermal scapular insertion site for the etonogestrel contraceptive implant. Clure C; Sheeder J; Lazorwitz A Contraception; 2024 Jul; 135():110442. PubMed ID: 38552822 [TBL] [Abstract][Full Text] [Related]